About the Authors
- Maria J. Camões
-
Contributed equally to this work with: Maria J. Camões, Paula Paulo
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal
- Paula Paulo
-
Contributed equally to this work with: Maria J. Camões, Paula Paulo
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal
- Franclim R. Ribeiro
-
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal
- João D. Barros-Silva
-
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal
- Mafalda Almeida
-
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal
- Vera L. Costa
-
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal
- Nuno Cerveira
-
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal
- Rolf I. Skotheim
-
Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
- Ragnhild A. Lothe
-
Affiliations Department of Cancer Prevention, Institute for Cancer Research, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway
- Rui Henrique
-
Affiliations Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal, Department of Pathology, Portuguese Oncology Institute-Porto, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal
- Carmen Jerónimo
-
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Epigenetics Group, Research Centre of The Portuguese Oncology Institute, Porto, Portugal, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal
- Manuel R. Teixeira
-
* E-mail: manuel.teixeira@ipoporto.min-saude.pt
Affiliations Department of Genetics, Portuguese Oncology Institute-Porto, Porto, Portugal, Cancer Genetics Group, Research Centre of the Portuguese Oncology Institute-Porto, Porto, Portugal, Centre for Cancer Biomedicine, Faculty of Medicine, University of Oslo, Oslo, Norway, Department of Pathology and Molecular Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal
Competing Interests
The authors have declared that no competing interests exist.
Author Contributions
Conceived and designed the experiments: MRT. Performed the experiments: MJC PP JDBS MA VLC. Analyzed the data: MJC PP FRR. Contributed reagents/materials/analysis tools: NC RIS RAL RH CJ. Wrote the paper: MRT PP.